What question did this study set out to answer?

To evaluate the performance of multi-modal cancer screening in individuals with Li-Fraumeni syndrome (LFS) caused by TP53 variants.

Performance of Longitudinal Cancer Screening in Li-Fraumeni Syndrome

View Full Paper

Ask AI

Bookmark

Authors

Longitudinal study shows effective cancer screening in individuals with Li-Fraumeni syndrome, indicating early detection is crucial.

To evaluate the performance of multi-modal cancer screening in individuals with Li-Fraumeni syndrome (LFS) caused by TP53 variants.
Enrolled 145 individuals with germline TP53 variants in a longitudinal study.
Administered various screenings including WBMRI, breast MRI, mammography, and colonoscopy.
Conducted logistic regression analyses to assess diagnostic properties and screening test effectiveness.
772 annual screening visits resulted in 72 cancers/pre-cancers diagnosed, with 75% being screen-detected.
Whole-body MRI indicated a high sensitivity (94%) for detecting cancers and pre-cancers.
Overall screening protocol had a sensitivity of 71.7% and specificity of 89%.

Khincha et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark